Maureen Durkin is professor and chair of population health sciences and Waisman Center investigator at the University of Wisconsin-Madison. She received her undergraduate degree and Ph.D. in anthropology from the University of Wisconsin-Madison and her M.P.H. and Dr.P.H. degrees in epidemiology from Columbia University. Her research focuses on the epidemiology of neurodevelopmental disabilities and childhood injuries, both globally and within the United States. She has collaborated in the development of cross-cultural methods for epidemiologic studies of developmental disabilities and methods for surveillance of childhood injuries and disabilities. She has also directed international studies on the prevalence and causes of neurodevelopmental disabilities in low-income countries. Durkin is currently a principal investigator in the Autism and Developmental Disabilities Monitoring Network and other projects related to public health surveillance, epidemiology and care integration of autism and other developmental disabilities.
Maureen Durkin
Professor of population health sciences
University of Wisconsin-Madison
Explore more from The Transmitter
Infant Brain Imaging Study findings, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 23 March.
Infant Brain Imaging Study findings, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 23 March.
Trading places: What happens when neuroscience turns into machine learning, and machine learning turns into neuroscience?
Neuroscience has become increasingly concerned with prediction, and machine learning with causal explanation, with each field adopting methods from the other. I asked eight experts to weigh in on what we stand to learn from this exchange.
Trading places: What happens when neuroscience turns into machine learning, and machine learning turns into neuroscience?
Neuroscience has become increasingly concerned with prediction, and machine learning with causal explanation, with each field adopting methods from the other. I asked eight experts to weigh in on what we stand to learn from this exchange.
Exon-skipping approach boosts levels of key Rett syndrome protein
Deleting a small region of the MECP2 gene partially restored function in neurons derived from people with Rett-associated variants.
Exon-skipping approach boosts levels of key Rett syndrome protein
Deleting a small region of the MECP2 gene partially restored function in neurons derived from people with Rett-associated variants.